EP2552360A1 - Dispositif implantable dans des conduits biologiques - Google Patents

Dispositif implantable dans des conduits biologiques

Info

Publication number
EP2552360A1
EP2552360A1 EP11722884A EP11722884A EP2552360A1 EP 2552360 A1 EP2552360 A1 EP 2552360A1 EP 11722884 A EP11722884 A EP 11722884A EP 11722884 A EP11722884 A EP 11722884A EP 2552360 A1 EP2552360 A1 EP 2552360A1
Authority
EP
European Patent Office
Prior art keywords
rfid
microchips
interrogator
microchip
backscattered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP11722884A
Other languages
German (de)
English (en)
Inventor
Gaetano Marrocco
Cecilia Occhiuzzi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universita degli Studi di Roma Tor Vergata
Universita degli Studi di Roma La Sapienza
Original Assignee
Universita degli Studi di Roma Tor Vergata
Universita degli Studi di Roma La Sapienza
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universita degli Studi di Roma Tor Vergata, Universita degli Studi di Roma La Sapienza filed Critical Universita degli Studi di Roma Tor Vergata
Publication of EP2552360A1 publication Critical patent/EP2552360A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/88—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements formed as helical or spiral coils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
    • A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
    • A61B5/6862—Stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A61B5/0031—Implanted circuitry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/9155—Adjacent bands being connected to each other
    • A61F2002/91566—Adjacent bands being connected to each other connected trough to trough
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0001—Means for transferring electromagnetic energy to implants
    • A61F2250/0002—Means for transferring electromagnetic energy to implants for data transfer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0085—Identification means; Administration of patients

Definitions

  • the present invention relates to a medical device implantable in biological ducts of the human body with enhanced functions.
  • Medical devices that are implantable in biological ducts, such as stents, prostheses or more generally intravascular devices, are used in treatments for correcting changes of coronaries, central and peripheral arteries, veins, biliary ducts, oesophagus, colon, trachea, bronchi, ureter, urethra and for central and peripheral neurosurgical applications.
  • the main aim of these devices is to correct significant changes in the diameter of a blood vessel or of a duct. They are often used for increasing the diminished flow of blood, or some other fluid, to organs downstream of an obstruction or for mechanically supporting the walls of vessels weakened and deformed by age, diseases or injuries.
  • neointima is variable but can be so substantial that it completely occludes the lumen of the duct, especially in the case of vessels of small diameter, often necessitating a new intervention.
  • the commonest problems are formation of new occlusions, as well as degradation of the structural integrity of the device and possible migration of all or parts of the structure from the place of implantation.
  • the technology of the prior art focuses mainly on reduction of growth of neointima after placement of the device: the use of biocompatible materials, the use of special drugs released from the device itself (drug-eluting device) and absorbable implants have produced notable improvements but so far have not solved the problem.
  • the diagnosis of the state of implanted intravascular devices is entrusted to echo(colour)-Doppler, which is able, in the vast majority of cases, to perform a diagnosis not only of the degree of restenosis, based essentially on the increase in flow velocity in the stretch of interest, but also of the typology and morphology of the restenotic plaque.
  • the other diagnostic techniques such as IVUS, TC or angio-RM with contrast medium (in exceptional cases traditional angiography) are reserved for doubtful and symptomatic cases in which surgical correction of restenosis is presumed to be suitable.
  • Document WO2005/046467 describes a telemetry system for monitoring the state of a biological duct based on a stent, one or more dedicated sensors (optionally active) and a system for communicating with the exterior, which in particular embodiments is an RFID tag but different from the implantable medical device, said RFID tag including two separate elements such as a microchip and an antenna.
  • This RFID tag can perform functions of localization, identification and storage of data relating to the medical device and to the patient in whom it is implanted.
  • the aforementioned tag can also perform sensory functions only if suitably integrated with active sensors and provided with a power supply.
  • the system described necessarily requires an autonomous power source which must be replenished from outside at regular time intervals, or which imposes various time limits on the use of said device, and moreover it must be provided with additional control electronics, increasing its invasiveness.
  • the foregoing therefore precludes its application in particularly sensitive biological contexts, such as those relating to cardiology and neurology.
  • a disadvantage of this solution is that it does not permit easy, unambiguous identification of the implanted device, because the response signal of the device is not immediately identifiable, especially when several stents are present.
  • this solution does not allow information regarding said device, the patient, the implantation surgery and its follow-up to be stored in the medical device.
  • the primary aim of the present invention is to provide a device that is implantable in biological ducts and has additional functionalities of identification and monitoring of the device itself, monitoring of the state of health of the duct in which it is implanted, localization and data storage, with a minimum number of electronic components and without local sources of power.
  • a further aim of the present invention is to provide an implantable device that is completely passive from the energy standpoint, which requires minimal variations in geometry with respect to a standard implantable device, so that it can be used with the normal implantation procedures.
  • Another aim of the invention is to provide a monitoring system and an associated process for monitoring the state of endothelialization and patency of biological ducts by means of said device.
  • the present invention proposes to achieve the aims discussed above by providing a device implantable in biological ducts having the features of claim 1 , a monitoring system having the features of claim 10, and a monitoring process comprising the stages of claim 17.
  • the medical device of the invention performs simultaneously the function of intravascular aid by virtue of its geometry, the function of radio transmitter for transmitting signals responding to interrogating signals sent from a remote interrogator, the function of sensor of the state of the duct and the function of data storage unit by means of suitable integration of one or more microchips for radio- frequency identification (RFID) in the structure of said device.
  • RFID radio- frequency identification
  • the proposed invention applies RFID technology to the problem of monitoring the endothelialization of intravascular devices and restenosis. It consists of a new class of medical devices made with biocompatible materials and conventional shapes, but integrated with one or more digital modulators of the RFID microchip type, having simultaneously mechanical, sensory and transmission functionalities, without the addition of specific sensors, batteries or antennas.
  • the conductive structure whether it is metallic or polymeric, which performs the true functions of a stent or of a general vascular support, is designed so that it also acts as an antenna.
  • the device of the invention When interrogated from the outside by a reader, which can be of portable or fixed type, but not necessarily placed just a few centimetres from the human body, the device of the invention supplies a response that is correlated with the variation in dimensions of the lumen in question, optionally also discriminating the nature of the neoformation.
  • This new family of implantable devices therefore allows various innovative functionalities to be performed, in addition to the therapeutic functionalities, which currently are not possible by means of a single device, namely:
  • the device makes it possible to extend the safety of the medical procedure beyond the existing limits and in particular to monitor, simply and inexpensively, the post-implantation course, even away from hospital facilities (pharmacies, consulting rooms and private dwellings), providing the doctor with useful information for a targeted planning of any analyses and/or adjustment of drug therapy.
  • the proposed invention offers additional functionalities of identification, monitoring and localization, which moreover make it possible to extend the market potential of intravascular devices also to the fields of diagnosis and of health service logistics.
  • Fig. 1 shows a schematic diagram in which the device of the invention is implanted in a human body
  • Fig. 2 shows an enlarged detail of a first preferred embodiment of the device
  • Fig. 3 shows an enlarged detail of a second embodiment of the device of the invention
  • Fig. 4 shows an enlarged detail of a third embodiment of the device of the invention
  • Fig. 5 shows an enlarged detail of a fourth embodiment of the device of the invention
  • Fig. 6 shows an enlarged detail of a fifth embodiment of the device of the invention.
  • Fig. 7 shows a schematic diagram of the main components of an external interrogator
  • Fig. 8 shows a schematic diagram of the principle of operation of the device of the invention.
  • Fig. 9 is a graph showing the variation of the signal received from the device in various situations of the biological duct.
  • Fig. 10 shows a schematic diagram of a further manner of operation of the device of the invention.
  • Fig. 1 1 shows a schematic diagram of a further situation of operation of the device of the invention
  • Fig. 1 2 shows a schematic diagram of a further manner of operation of the device of the invention
  • Fig. 1 3 shows an example of organization of the information contained in the memory of the device of the invention.
  • the implanted device 200 when it is exposed to electromagnetic radiation emitted by a remote radio-frequency device, conventionally called interrogator 100, the implanted device 200, for example in the form of a stent or graft or vascular prosthesis, produces, like any metallic conductor, a backscattered electromagnetic field.
  • the characteristics of intensity and spatial distribution of the backscattered field depend on the shape of the device, the material of which it is composed and the surrounding region of the body, indicated as parameters ⁇ - ⁇ , ⁇ 2 ⁇ ⁇ . ⁇ ) in Fig. 1 .
  • the quantity used for describing the electromagnetic field backscattered by a general object is its radar cross-section, as it is commonly defined in English. If the site of implantation of the device undergoes, over time, chemical and physical changes with respect to an initial condition, as a result of phenomena of plaque formation or of regrowth of tissue, which lead to a change in the patency of the duct, which can be indicated with the parameters ⁇ ' ⁇ , ⁇ '2 ⁇ .. ⁇ ' ⁇ ) ⁇ ⁇ ⁇ 1 . ⁇ 2 ⁇ ⁇ ⁇ ⁇ ) in Fig. 1 , the radar cross- section of the implanted device 200 will undergo corresponding changes.
  • the intensity or the phase of the backscattered field collected by the interrogator 100 will incorporate information on the state of the duct, making it possible, in theory, to perform remote monitoring of changes in the state of the duct, for example remote monitoring of the degree of endothelialization of the device or remote monitoring of a phenomenon of restenosis if the device is a stent.
  • the intravascular device of the invention in this form, can then also be regarded as a sensor of the change in the state of the duct in which it is implanted.
  • the therapeutic and diagnostic functionalities are not separable since they are performed by a single physical object. In the devices of the prior art, remote monitoring of this kind cannot be achieved, for the following physical reasons:
  • the electromagnetic field backscattered by the device is a function of the inclination and of the distance of the implanted device with respect to the interrogator; therefore to evaluate a change in the state of the site of implantation it would be necessary to reproduce, in successive measurements, the identical mutual position between interrogator and site of implantation, the latter not being easily mappable on the outside surface of the patient's body; (in reality this problem is only overcome with the impedance interrogator but not with the other two)
  • one or more microchips for radio-frequency identification commonly called RFID microchips, which cause the device to reflect the interrogating electromagnetic field according to digital modulation, i.e. generating an unambiguous and recognizable code, are suitably integrated in the structure of the implantable device, for example a stent.
  • the interrogator will, by means of demodulation and decoding, be able to identify unambiguously the specific contribution of the device itself, independently of the conditions of measurement and of the variation of the outside environment, which instead induce variations in the backscattered electromagnetic field that are unmodulated, and so can easily be eliminated.
  • the radar cross-section of this implantable device can be likened to that of an antenna connected to a network of variable impedances and depends on the gain of said antenna and on matching the impedances of the various RFID microchips with the impedances of the conducting structure, taken at the points of interruption and insertion of the RFID microchips.
  • Both the gain and the input impedances of the implantable device of the invention being macroscopic characteristics, will also be determined by the state of the duct in which the device is implanted and will in their turn influence the electromagnetic field backscattered by said device.
  • the device of the invention in addition to the functions of medical device and of sensor, also incorporates the function of a radio, which is able to establish communication with the interrogator, in accordance with suitable protocols.
  • a radio which is able to establish communication with the interrogator, in accordance with suitable protocols.
  • the operation of the device of the invention envisages that the interrogator 100 emits an electromagnetic interrogating signal S read . Via this signal, the implantable device 200 receives the energy required for activation of one or more RFID -microchips that are incorporated therein and retransmits an electromagnetic signal S RFID (t.,), modulated by said RFID microchips supplying the identification code of the device.
  • S RFID electromagnetic signal
  • the backscattered signal at time t v S RFID (t.,) will be conditioned in amplitude and phase by the detected state of the duct, indicated by the sequence of parameters ⁇ , ⁇ 2 ⁇ . ⁇
  • the interrogation by the interrogator 100 is carried out at a time t2, at which the biological duct has undergone changes so that the parameters ⁇ , ⁇ ' 2 ... ⁇ ' ⁇ are different from ⁇ - ⁇ , ⁇ 2 ... ⁇ ⁇ ⁇ , the chemical, physical and geometric characteristics of the implanted device will be altered in relation to said changes, so that the retransmitted signal, S RFID (t 2 ), will be different from the previously backscattered signal S ⁇ t.,).
  • Said changes, suitably processed by the interrogating unit will supply information on the state of the duct detected by the device itself.
  • the device of the invention is an intravascular device made partially or completely with wires made of electrically conducting metal alloys, optionally with shape memory properties such as Nitinol, produced in a continuous form or as a mesh, namely by assembly of wires that can also be shaped in a base form such as rings with a profile of uniform or variable section and segments of wires interconnected in conventional ways, specific for the anatomical site of the implant.
  • the base forms for example rings, can be stacked vertically optionally along bifurcations for adapting to particular biological ducts, for example the oesophagus or the abdominal aorta.
  • the metallic structure constituted of the wires can moreover be supported by a surface of biocompatible dielectric material.
  • metal alloys it is possible to use electrically conducting polymers or conductors that are bioabsorbable by the human body.
  • the introduction of one or more RFID microchips 201 in the conducting structure that constitutes an intravascular device 200 interrupts the conducting ring locally at one or more points.
  • One or more RFID microchips 201 are introduced on said conducting rings or wires 202, by welding or gluing or mechanically pressing or crimping the two terminals of the RFID microchip near the interruption, in order to restore the mechanical and functional continuity of the structure, as illustrated in Fig. 2.
  • each RFID microchip 201 is connected to the closed conducting wire or ring 202, without causing its interruption by adding, in parallel, a stretch of a further shaped conducting wire 203, interrupted by interconnecting a respective RFID microchip 201 as described above, one end of which 204 or both ends are fixed by welding, gluing or crimping to said closed conducting wire 202, as illustrated in Fig. 3.
  • the features of the embodiment in Fig. 3 can be combined with the features of Fig. 2.
  • the single RFID microchip 201 is connected to two or more closed conducting wires 202 by means of an additional conductor 204', transverse with respect to the closed wire conductors 202, interrupted by interconnecting the RFID microchip, the two ends of which are fixed by welding, gluing or crimping to said closed wire conductors.
  • This variant is illustrated in Fig. 4. The features of the variant in Fig. 4 can be combined with the features of Figs. 2 and 3.
  • the device of the invention 200 is obtained by processing a single block of metal alloy and the various RFID microchips 201 are housed in slots or slits 205 that are more or less articulated, pre-existing or created suitably in the device; this variant is illustrated in Fig. 5.
  • Fig. 6 finally, illustrates a further variant of the device of the invention, in the form of a stent 200 having a tubular mesh structure. At predetermined points of the mesh 224, one or more RFID microchips 201 are introduced, welding or gluing or mechanically pressing or crimping the two terminals of the RFID microchip near the interruption, in order to restore the mechanical and functional continuity of the structure.
  • the RFID microchips are identified by different identification codes, established on initialization of the device of the invention, and stored in their internal memory.
  • the internal memories of the RFID microchips can in addition contain logistic information about the life of the device, about the patient, about the surgical intervention and about the post-implant diagnostic tests.
  • the mechanical (shape) and electrical (position of the microchips) design of the device of the invention must ensure appropriate sensitivity of the radar cross- section of said device to variation of the state of patency of the duct.
  • the shape of the implantable device and the positioning of the microchips are optimized with instruments for electromagnetic simulation, having, as the desired result, the variation of the input impedance at the various points of interruption of the conductor with variation of the state of patency of the duct. This variation in impedance is fixed by the designer following simulations for reference cases and experimental studies on biological models.
  • the implantable device is designed so that at least one microchip is always sufficiently matched, regardless of the condition of the state of patency of the duct, and the code transmitted by it constitutes the unique identifier of the device.
  • the remaining RFID microchips may or may not be able to transmit the own digital code in relation to the state of the duct.
  • the subset of codes transmitted is part of the information processed by the interrogator in the diagnostic procedure.
  • a monitoring system comprises the medical device 200 and the external interrogator or reader 100.
  • the interrogator 100 supplies energy to the implantable device by means of electromagnetic waves, as well as supplying the carrier for the modulation introduced by the RFID microchip.
  • the interrogator interrogates the various RFID microchips, acquires the codes transmitted by the microchips and the signals associated with them, processes one or more parameters to be correlated with the state of the device and optionally stores information in the RFID microchips' own memory.
  • Fig. 7 shows a schematic representation of the main components of the external interrogator 00.
  • This includes a radio-frequency or microwave radio transmitter 102, a control logic 103, one or more antennas 101 and a series of components dedicated to implementation of the sensing algorithm.
  • the interrogator is capable of performing the task of processing the responses of the device 200 (producing specific diagnostic indicators) and of writing the results of the periodical checks of the state of health of the biological duct in the memories of the RFID microchips 201.
  • the electronic blocks that permit execution of acquisition and processing of the sensory data are:
  • first electronic subsystem 104 that interrogates the implantable device 200 with increasing power of emission until the minimum power is identified for turn-on of each of the RFID microchips 201 integrated in the implantable device.
  • This first electronic subsystem 104 is able to perform said interrogation at a multiplicity of different frequencies and to store the values of said frequencies. Moreover, it is configured so as to associate with the minimum turn-on powers of the RFID microchips, integrated in the implantable device, the state of health of the biological vessel by means of conversion tables or graphs stored in the reader;
  • a second electronic subsystem 105 that stores the power backscattered by each of the RFID microchips 201 , integrated in the implantable device 200, in the condition of minimum turn-on power of said microchips or in the condition of maximum allowed power of emission.
  • This second electronic subsystem 105 is able to store these powers backscattered at different frequencies. Furthermore it is able to store separately the powers backscattered by the RFID microchips for a fixed value of power of emission. Lastly, it is configured so as to correlate these backscattered powers with the state of health of the biological duct by means of conversion tables or graphs stored in the reader;
  • a third electronic subsystem 106 configured for combining and processing the minimum turn-on powers of each of the RFID microchips and the powers backscattered from each of said RFID microchip at the various frequencies used for obtaining a measurement indicator independent of the spatial orientation between reader and implantable device and that can be correlated with the state of health of the biological duct by means of conversion tables or graphs stored in the reader.
  • the remote interrogator 100 provides for interrogation of the implanted device 200 in three modalities.
  • the interrogation procedure of the monitoring process according to the invention envisages the steps of:
  • each n-th RFID microchip in a second interrogation modality the reader interrogates selectively, by means of the first electronic subsystem 104, each n-th RFID microchip with an electromagnetic signal S rea d at increasing power of emission until said n-th RFID microchip is activated and transmits back its identification code.
  • the reader stores the respective power indicator at time t; d) the reader 100 repeats the steps from a) to c'), from a) to c") or from a) to c'") at increasing frequency until the entire operating range of the RFID microchips is covered.
  • the whole procedure for interrogation and correlation of the measured indicator with the evolution of the state of the biological duct can be outlined as follows: - once the medical device 200 has been implanted in the biological duct, the external reader 100 executes the steps from a) to d) following one of the three interrogation modalities, storing their data as initial reference condition in the memory of the reader and/or in the memory of the RFID microchips integrated in the implanted device. Furthermore, the reader can store the registration data of the device and information relating to the intervention;
  • the reader 100 performs the following operations:
  • the state of the implanted device or of the biological duct can also be assessed based on the effective number of microchips that respond to interrogation by the reader 100, making use of conversion tables and/or reference graphs (e.g. Fig. 9).
  • the device of the invention 200 gives information, as illustrated in Fig. 8, about the variations in patency of the duct, in particular the change in longitudinal extension H of the layer 210 of endothelialization and/or restenosis and the change in radius R of portion 220 of the biological duct not occupied by said layer 210 (see Ri and Hi on the left and R 2 and H2 on the right in Fig. 8), as a change in its dimension and electrical form and reacts by changes of its radar cross-section and of the signal backscattered to the interrogator.
  • FIG. 9 An example of signal received by the interrogator, with variation of the degree of endothelialization and/or of restenosis, is shown in Fig. 9.
  • This signal is obtained from a computer simulation of a device implanted in a tubular duct of dimensions comparable to a carotid artery.
  • the device of the invention, implanted, is interrogated at a frequency of 870 MHz, which is allocated in Europe to UHF RFID communications.
  • the graph shows the variation of the signal received by the external interrogator on increasing the degree of shrinkage of the lumen or portion of duct 220, defined as (Ro-R)/Ro, where R 0 is the radius of the duct in the initial conditions post-intervention and R is the radius of the duct in the various detections, for two different types of process, neointimal and atherosclerotic.
  • This curve which is found to be monotonic and increasing, has the direction of an inversion curve, in the sense that it makes it possible to associate, unambiguously, a change in the degree of occlusion of the duct with the variation of the signal received.
  • the curves associated with the two processes - neointimal and atherosclerotic - have a different slope and therefore processing of the signal received, in successive measurements, would also make it possible to distinguish the type of restenosis.
  • the device of the invention 200 reacts to the variations of the state of the duct 250 in which it is placed, indicated by the sequence of parameters ⁇ 1 , 4 , ⁇ . by change of shape, and in the specific case passing from a radius R 3 to a radius R of duct 250, and finally altering its radius of curvature as illustrated in Fig. 10.
  • the change in shape leads to a change of the radar cross-section of the device and therefore of the signal backscattered to the interrogator.
  • the device of the invention 200 implanted in a biological duct, has suffered, in the operating conditions, a disconnection between the modules of which it is composed. This deformation will produce a 2011/051436
  • the device of the invention is a Y-shaped stent 200 to match the bifurcation of a long biological duct.
  • the device contains a multiplicity of RFID microchips 201 spatially arranged, making it possible to monitor each portion of the device independently.
  • Fig. 12 also shows, on the right, a possible temporal variation of the signal arriving from the aforementioned Y-shaped stent 200 and collected by the external interrogator 100.
  • the implanted device involves the terminal portion of the abdominal aorta and its final bifurcation into the two iliac arteries.
  • the RFID microchips 201 are arranged so as to monitor the three anatomical compartments independently, supplying at each control time ⁇ TO, T1 , T2.... ⁇ specific information on their degree of endothelialization and/or restenosis (expressed as percentages) and consequently to locate the position of obstructions and/or absence of endothelial proliferation.
  • the graph clearly shows the different evolution of the obstruction of the abdominal aorta and of the left common iliac artery.
  • a fifth example shows a possible organization of the memory of the.
  • RFID microchips 201 placed in the device of the invention so as to contain the registration data of the device, the manufacturer, the distributor, the date of implantation, the references of the doctor and of the surgical team that carried out the intervention and the dates and results of regular check-ups, these functioning as the pedigree of the device and the patient's medical record card, which can be updated instantly at each interaction with the interrogator 100, even outside of the medical facility.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cardiology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Thermotherapy And Cooling Therapy Devices (AREA)

Abstract

La présente invention concerne un dispositif médical (200) qui peut être implanté dans des conduits biologiques du corps humain, doté de fonctionnalités simultanées d'aide mécanique pour des conduits biologiques, de capteur de l'état d'obstruction du conduit, d'émetteur radio et d'unité de stockage de données. Le dispositif est constitué d'alliages métalliques biocompatibles; et une ou plusieurs micropuces d'identification par radiofréquence (RFID) pourvues d'une mémoire, aptes à surveiller leur propre degré d'endothélialisation, détectent la présence et l'évolution de processus sténotiques, et localisent le dispositif, le reconnaissent, évaluent son intégrité structurelle et transmettent les informations recueillies à un lecteur externe adapté au moyen de la réflexion du champ électromagnétique émis par l'interrogateur externe. Les fonctionnalités du dispositif permettent en outre le traçage de l'ensemble de l'historique du dispositif et des données médicales d'un patient.
EP11722884A 2010-04-02 2011-04-04 Dispositif implantable dans des conduits biologiques Withdrawn EP2552360A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000153A ITRM20100153A1 (it) 2010-04-02 2010-04-02 Dispositivo impiantabile in condotti biologici
PCT/IB2011/051436 WO2011121581A1 (fr) 2010-04-02 2011-04-04 Dispositif implantable dans des conduits biologiques

Publications (1)

Publication Number Publication Date
EP2552360A1 true EP2552360A1 (fr) 2013-02-06

Family

ID=42562480

Family Applications (1)

Application Number Title Priority Date Filing Date
EP11722884A Withdrawn EP2552360A1 (fr) 2010-04-02 2011-04-04 Dispositif implantable dans des conduits biologiques

Country Status (3)

Country Link
EP (1) EP2552360A1 (fr)
IT (1) ITRM20100153A1 (fr)
WO (1) WO2011121581A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102011013308B4 (de) * 2011-03-07 2013-09-19 Christian-Albrechts-Universität Zu Kiel Hochfrequenz-resonante Stents für das nicht-invasive Restenose-Monitoring
FR3026631B1 (fr) 2014-10-03 2016-12-09 Ecole Polytech Dispositif medical implantable muni de capteurs
FR3049843A1 (fr) * 2016-04-06 2017-10-13 Instent Dispositif medical muni de capteurs

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6625600A (en) * 1999-08-14 2001-03-13 B.F. Goodrich Company, The Remotely interrogated diagnostic implant device with electrically passive sensor
US6729336B2 (en) * 2001-11-27 2004-05-04 Pearl Technology Holdings, Llc In-stent restenosis detection device
US7416530B2 (en) * 2003-11-04 2008-08-26 L & P 100 Limited Medical devices
WO2007081741A2 (fr) * 2006-01-04 2007-07-19 Massachusetts Institute Of Technology Système de surveillance de circulation de fluide sans fil implantable

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2011121581A1 *

Also Published As

Publication number Publication date
ITRM20100153A1 (it) 2011-10-03
WO2011121581A1 (fr) 2011-10-06

Similar Documents

Publication Publication Date Title
Occhiuzzi et al. Design of implanted RFID tags for passive sensing of human body: The STENTag
US11547352B2 (en) Method and apparatus for measuring flow through a lumen
US10092363B2 (en) Intelligent catheter
US7429920B2 (en) Radio frequency identification and tagging for implantable medical devices and medical device systems
US20150164372A1 (en) Intelligent implanted health sensing device and assembly
CN104254273A (zh) 监测和诊断系统及方法
WO2015126703A1 (fr) Procédés d'évaluation d'un écoulement de fluide dans un conduit
Springer et al. Aneurysm sac pressure measurement with minimally invasive implantable pressure sensors: an alternative to current surveillance regimes after EVAR?
Occhiuzzi et al. Human body sensing: A pervasive approach by implanted RFID tags
WO2011121581A1 (fr) Dispositif implantable dans des conduits biologiques
Nappi et al. RF detection of micro-cracks in orthopedic implants by conformal space filling curves
EP3267878B1 (fr) Position d'un capteur sur une prothèse permettant de détecter une sténose
US11272840B2 (en) Touch probe passively powered wireless stent antenna for implanted sensor powering and interrogation
Gagliardi et al. How to transform an aortic valve prostheses into an UHF antenna for the RFID-based wireless monitoring of the cardiac health
US20220338808A1 (en) Methods and systems for sensing parameters in implantable devices
US20240000590A1 (en) Implantable devices with tracking, and related systems and methods
CN115414163B (zh) 血管支架、人体血管局部变形与血管局部动力学监测系统
Murphy et al. RF communication with implantable wireless device: effects of beating heart on performance of miniature antenna
Lee et al. Spatial orientation and morphology of the pulmonary artery: relevance to optimising design and positioning of a continuous pressure monitoring device
Lynch et al. A review of methods for determining the long term behavior of endovascular devices
WO2024031014A1 (fr) Surveillance d'endofuites
Naccarata et al. Continuous Detection of Fluid Leaks Into the Body by Means of Partially Dissolvable Antennas
CN118102967A (zh) 植入物
Santos et al. A Possibility for Pos-EVAR Surveillance: a Novel Smart Stent-graft

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20121031

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20130807

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20140218